loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X

List of Written Confirmation(s) issued for Pretomanid (PA-824) Active Pharmaceutical Ingredient (API)

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 M/s Mylan Laboratories Limited (1)

filter

01 Pretomanid IH (1)

filter

01 WC-0016n (1)

filter

01 India (1)

URL Supplier Web Content
WC-0016n
(Unit IX), Plot No. 5, Road No. 12, Jawahar Nehru Pharma City, Tadi (V), Parawada Mandal, Visakhapatnam-535021, A.P
2025-06-26
2022-06-15
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for 187235-37-6 / Pretomanid API manufacturers, exporters & distributors?

Pretomanid manufacturers, exporters & distributors 1

94

PharmaCompass offers a list of Pretomanid API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Pretomanid manufacturer or Pretomanid supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pretomanid manufacturer or Pretomanid supplier.

PharmaCompass also assists you with knowing the Pretomanid API Price utilized in the formulation of products. Pretomanid API Price is not always fixed or binding as the Pretomanid Price is obtained through a variety of data sources. The Pretomanid Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Pretomanid

Synonyms

Pa-824, 187235-37-6, Pa 824, Pa824, (s)-2-nitro-6-((4-(trifluoromethoxy)benzyl)oxy)-6,7-dihydro-5h-imidazo[2,1-b][1,3]oxazine, (s)-pa 824

Cas Number

187235-37-6

Unique Ingredient Identifier (UNII)

2XOI31YC4N

About Pretomanid

Persistent forms of tuberculosis (TB) have proven to be a major cause of global morbidity and mortality and a cause for significant concern. Research in recent years has been geared toward the development of novel therapies that target persistent forms of this disease, which have shown resistance to standard therapy regimens. Pretomanid is an antimycobacterial agent that is administered with [Bedaquiline] and [Linezolid] to treat resistant forms of pulmonary TB. It was the first TB drug developed by a nonprofit organization, known as TB Alliance, and was granted FDA approval on August 14, 2019. Unlike other therapeutic regimens for the treatment of resistant TB, which may take 18 months or longer and may not be effective, the pretomanid-containing regimen allows for a more efficacious and shorter duration of treatment with fewer drugs.

Pretomanid (PA-824) Manufacturers

A Pretomanid (PA-824) manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pretomanid (PA-824), including repackagers and relabelers. The FDA regulates Pretomanid (PA-824) manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pretomanid (PA-824) API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

Pretomanid (PA-824) Suppliers

A Pretomanid (PA-824) supplier is an individual or a company that provides Pretomanid (PA-824) active pharmaceutical ingredient (API) or Pretomanid (PA-824) finished formulations upon request. The Pretomanid (PA-824) suppliers may include Pretomanid (PA-824) API manufacturers, exporters, distributors and traders.

click here to find a list of Pretomanid (PA-824) suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Pretomanid (PA-824) WC

A Pretomanid (PA-824) written confirmation (Pretomanid (PA-824) WC) is an official document issued by a regulatory agency to a Pretomanid (PA-824) manufacturer, verifying that the manufacturing facility of a Pretomanid (PA-824) active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Pretomanid (PA-824) APIs or Pretomanid (PA-824) finished pharmaceutical products to another nation, regulatory agencies frequently require a Pretomanid (PA-824) WC (written confirmation) as part of the regulatory process.

click here to find a list of Pretomanid (PA-824) suppliers with Written Confirmation (WC) on PharmaCompass.

Pretomanid (PA-824) Manufacturers | Traders | Suppliers

Pretomanid (PA-824) Manufacturers, Traders, Suppliers 1
76

We have 1 companies offering Pretomanid (PA-824)

Get in contact with the supplier of your choice:

  1. Viatris
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Post Enquiry
POST ENQUIRY